Results 11 to 20 of about 34,871 (236)

Radiopharmaceuticals in cardiology [PDF]

open access: yesNuclear Medicine Review, 2012
Myocardial perfusion studies are among the most often performed investigations in Nuclear Medicine. However, the development of radiopharmaceuticals for cardiology is an emerging discipline and several other radiotracers have been proven to be useful.
Renata, Mikołajczak, Piotr, Garnuszek
openaire   +4 more sources

Development Strategy for Innovation System of Radiopharmaceuticals in China [PDF]

open access: yes中国工程科学, 2022
Nuclear medicine plays an irreplaceable role in the diagnosis, therapy, and prognosis of various diseases. Radiopharmaceuticals are the cornerstone of nuclear medicine; their systematic development could accelerate the innovation and clinical application
Peng Shuming   +5 more
doaj   +2 more sources

Recent Advances and Strategies in the Development of Therapeutic Radiopharmaceuticals [PDF]

open access: yesJournal of Isotopes
Therapeutic radiopharmaceuticals can be employed in the treatment of various tumor diseases,and their global market share is likely to witness an explosive growth in the recent decade.
Mianxue LIU   +8 more
doaj   +3 more sources

Nano-radiopharmaceuticals as therapeutic agents [PDF]

open access: yesFrontiers in Medicine
In recent years, there has been an increased interest in exploring the potential synergy between nanotechnology and nuclear medicine. The application of radioactive isotopes, commonly referred to as radiopharmaceuticals, is recognized in nuclear medicine
Tanu Dixit   +5 more
doaj   +2 more sources

Strategies for Innovative Development of Tumor-targeted Theranostic Radiopharmaceuticals [PDF]

open access: yesYuanzineng kexue jishu
Radiopharmaceutical is an essential component of nuclear medicine and have demonstrated significant potential in disease diagnosis and treatment. In recent years, several tumor-targeted theranostic radiopharmaceuticals have been approved for market ...
HUANG Xuhu1, 2, 3, CHEN Huan1, 2, 3, LI Kexin1, 2, 3, WANG Ning1, 2, 3, ZHUANG Jin1, 2, 3, LI Hongyu1, 2, 3, DU Jin2, 3, 4
doaj   +3 more sources

Evidence-Based Data About Prevalence and Risk of Malignancy of Thyroid Incidentalomas Detected by Different PET Radiopharmaceuticals. [PDF]

open access: yes, 2020
To date, several meta-analyses and systematic reviews have reported data about the prevalence and risk of malignancy of thyroid incidentalomas detected by different PET radiopharmaceuticals.
Albano, D.   +4 more
core   +3 more sources

Radiopharmaceuticals [PDF]

open access: yes, 2022
Radiopharmaceuticals - Current Research for Better Diagnosis and Therapy discusses the importance of radiopharmaceuticals and their environmental, pharmaceutical, diagnostic, therapeutic, and research applications.

core   +1 more source

Adverse reactions to radiopharmaceuticals [PDF]

open access: yesFarmacia Hospitalaria, 2021
Spanish Royal Legislative Decree 1/2015 of July 24 considered radiopharmaceuticals to be drugs subject to current legislation on this matter. After Radiopharmaceuticals are prepared in Radiopharmacy Departments, they are administered to patients to ...
María del Val Gómez-Martínez   +4 more
doaj   +1 more source

Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals

open access: yesMolecules, 2021
Hydroxypyridinones (HOPOs) have been used in the chelation therapy of iron and actinide metals. Their application in metal-based radiopharmaceuticals has also been increasing in recent years.
Xu Zhou, Linlin Dong, Langtao Shen
doaj   +1 more source

Preparation and Bioevaluation of a Novel 99mTc-Labeled Glucose Derivative Containing Cyclohexane as a Promising Tumor Imaging Agent

open access: yesPharmaceuticals, 2023
To develop novel tumor imaging agents with high tumor uptake and excellent tumor/non-target ratios, a glucose derivative containing cyclohexane (CNMCHDG) was synthesized and labeled with Tc-99m.
Junhong Feng   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy